and intervention are critical to lowering death and disability rates, but currently only invasive methods are available to monitor increased ICP. Invasive methods are associated with risk of bleeding and infections, are only available at larger hospitals and have a considerable cost. While invasive intracranial pressure monitoring has been available for many years, non-invasive measurement has so far not been accurate enough.

Nisonic is developing an software that analyzes ultrasound images of the eye to monitor increased ICP, and that can be integrated into ultrasound devices on the market, enabling widespread use among physicians and other health workers.